PRENW — Prenetics Global Limited

Summary of Prenetics Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 Revenue: $36.6 million, a 457% increase year-over-year and a 55% sequential increase from Q3.
• Full Year 2025 Revenue: $92.4 million, up approximately 480% from 2024.
• Gross Profit Q4 2025: $21.7 million, with a gross margin of 59%, reflecting an 804% year-over-year increase.
• Adjusted EBITDA: Loss of $2.3 million in Q4, a 70.4% improvement from the prior year; full-year adjusted EBITDA loss improved by 27% to $13 million.
• IM8 Revenue: Contributed $27.4 million in Q4 and $60.1 million for the full year, with a gross margin of 63%.

2. Strategic Updates and Business Highlights

• Transformation: Prenetics underwent a strategic pivot to focus solely on consumer health, divesting non-core assets, including ACT Genomics and Insighta, which enhanced liquidity and margin profile.
• IM8 Growth: The IM8 brand, co-founded with David Beckham, achieved a $120 million annualized revenue run rate in its first year, with significant international presence (40% U.S. revenue, 60% international).
• Customer Acquisition Strategy: Shifted to quarterly subscriptions, increasing average order value from $110 to $233 and achieving an 80% new customer subscription rate.
• AI Utilization: Implemented AI in digital marketing, optimizing ad performance and enhancing customer engagement.

3. Forward Guidance and Outlook

• 2026 Revenue Guidance: Expected IM8 revenue of $180 million to $200 million, representing nearly 300% year-over-year growth.
• Gross Margin Target: Approximately 60% for 2026.
• Adjusted EBITDA Loss: Projected between $16 million to $20 million for 2026, with a path to adjusted EBITDA profitability by Q4 2027.

4. Bad News, Challenges, or Points of Concern

• Adjusted EBITDA Loss: Despite improvements, the company continues to operate at a loss, indicating ongoing challenges in achieving profitability.
• Customer Acquisition Costs: While CAC has remained stable, the increase in average order value may not fully mitigate the costs associated with customer acquisition.
• Market Competition: The company is entering competitive markets with new products, which may pose risks to achieving projected growth.

5. Notable Q&A Insights

• Customer Acquisition and Revenue Growth: Majority of growth expected from new customer acquisition rather than increased revenue per user.
• Product Launches: Two new SKUs planned for Q4 2026, targeting large addressable markets, though not included in revenue guidance.
• International Expansion: Localization efforts are anticipated to yield a 10-15% revenue uplift in targeted international markets.
• M&A Strategy: Focus on organic growth, with potential for strategic acquisitions if beneficial opportunities arise.

Overall, Prenetics showcased impressive growth driven by the IM8 brand while navigating challenges related to profitability and market competition. The company remains optimistic about future growth and strategic initiatives.